Japan's Astellas to acquire Audentes in $3.0B deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Japan's Astellas Pharma will acquire the US drugmaker Audentes Therapeutics in a deal worth $3.0B, seeking to boost its growth in the genetic medicines area.
Back to articles

Actual Topics

Thu, 05 Dec 2019 02:59:51 GMT

Visco backs ESM reform

Ignazio Visco, the Governor of Italy's Central Bank, said on Wednesday that the European Stability Mechanism reform was a step in the right direction.

Wed, 04 Dec 2019 20:07:32 GMT

OPEC+ set to deepen oil trims amid Aramco IPO

OPEC is set to deepen oil trims, together with its allies, seeking to run the deal no later than June 2020 to deliver a positive result to the market ahead of the planned Saudi Aramco's IPO.

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.